Ibnsina Pharma (EGX:ISPH)

Ibnsina Pharma Ratios and Metrics

Market cap in millions EGP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	11,814	7,056	3,165	2,419	3,907	4,886
Market Cap Growth	80.86%	122.93%	30.83%	-38.08%	-20.04%	-39.01%
Enterprise Value	35,439	23,168	15,142	11,020	10,960	10,282
Last Close Price	11.72	6.90	3.10	2.13	3.23	4.04
PE Ratio	16.80	14.17	18.28	17.84	13.65	26.54
Forward PE	9.71	11.62	10.44	12.34	9.83	12.70
PS Ratio	0.16	0.13	0.09	0.11	0.18	0.26
PB Ratio	4.74	3.47	2.18	1.92	2.69	3.58
P/TBV Ratio	5.23	3.89	2.57	1.97	2.72	3.60
P/FCF Ratio	-	-	-	-	-	224.70
P/OCF Ratio	-	-	25.16	6.69	-	19.40
PEG Ratio	-	0.26	0.33	0.35	0.41	0.44
EV/Sales Ratio	0.49	0.42	0.45	0.50	0.50	0.55
EV/EBITDA Ratio	9.78	9.69	11.96	18.48	13.97	17.09
EV/EBIT Ratio	10.64	10.26	13.15	22.85	16.42	21.04
EV/FCF Ratio	-10.78	-	-	-	-	472.83
Debt / Equity Ratio	9.99	9.94	9.06	7.82	5.49	4.94
Debt / EBITDA Ratio	6.88	8.08	9.83	14.82	9.47	10.92
Debt / FCF Ratio	-	-	-	-	-	310.22
Asset Turnover	2.36	2.37	2.16	1.84	2.12	2.15
Inventory Turnover	9.08	10.53	10.82	8.30	9.02	9.08
Quick Ratio	0.68	0.67	0.68	0.60	0.66	0.48
Current Ratio	1.01	1.00	1.00	1.00	1.03	1.06
Return on Equity (ROE)	40.22%	35.32%	15.75%	12.60%	22.31%	17.36%
Return on Assets (ROA)	6.73%	5.98%	4.58%	2.50%	4.06%	3.51%
Return on Capital (ROIC)	9.00%	7.67%	5.60%	2.93%	4.75%	4.13%
Return on Capital Employed (ROCE)	95.40%	70.20%	43.90%	20.10%	35.40%	27.20%
Earnings Yield	5.95%	8.71%	6.75%	7.13%	8.05%	4.60%
FCF Yield	-27.84%	-16.82%	-7.21%	-18.05%	-12.49%	0.45%
Dividend Yield	1.37%	2.32%	-	-	2.66%	-
Payout Ratio	4.58%	4.17%	10.74%	81.35%	4.63%	36.51%
Buyback Yield / Dilution	-	-	-	22.58%	-16.25%	-
Total Shareholder Return	1.37%	2.32%	-	22.58%	-13.59%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.